...
首页> 外文期刊>Gene Therapy and Molecular Biology >A novel IL-6/IL-12 family cytokine IL-27 and itsantitumor activity
【24h】

A novel IL-6/IL-12 family cytokine IL-27 and itsantitumor activity

机译:新型IL-6 / IL-12家族细胞因子IL-27及其抗肿瘤活性

获取原文
           

摘要

Interleukin (IL)-12 is a heterodimeric pro-inflammatory cytokine, which plays a critical role in a link between innate and adaptive immunities and in the development of type 1 cell-mediated immunity. Novel heterodimeric cytokines IL-23 and IL-27 with structural and functional similarities to IL-12 have been identified. These novel cytokines establish the IL-6/IL-12 family, whereas they mediate distinct cellular functions and roles, resulting in the coordinate regulation of Th1 development and type 1 cell-mediated immunity. Recent studies have revealed that both IL-23 and IL-27 possess a potent antitumor activity. Although IL-12 has a powerful antitumor activity against various tumors, IL-12 therapy has been limited by its systemic toxicities. Therefore, IL-23 and IL-27 may be alternative attractive candidates as therapeutic agents against tumors. This review summarizes recent advance on the roles of IL-27 in immune regulation and its antitumor activity.
机译:白介素(IL)-12是一种异源二聚体促炎细胞因子,在先天免疫和适应性免疫之间的联系以及1型细胞介导的免疫的发展中起着关键作用。已经鉴定出与IL-12具有结构和功能相似性的新型异二聚细胞因子IL-23和IL-27。这些新颖的细胞因子建立了IL-6 / IL-12家族,但它们介导不同的细胞功能和作用,从而导致Th1发育和1型细胞介导的免疫的协调调节。最近的研究表明,IL-23和IL-27均具有有效的抗肿瘤活性。尽管IL-12具有针对各种肿瘤的强大抗肿瘤活性,但IL-12治疗受到其全身毒性的限制。因此,IL-23和IL-27可以是替代的有吸引力的候选物作为抗肿瘤的治疗剂。这篇综述总结了IL-27在免疫调节中的作用及其抗肿瘤活性的最新进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号